Matches in SemOpenAlex for { <https://semopenalex.org/work/W2083129612> ?p ?o ?g. }
- W2083129612 endingPage "362" @default.
- W2083129612 startingPage "357" @default.
- W2083129612 abstract "The authors had for aim to assess the effectiveness and toxicity of a piperacillin-tazobactam-netilmicin combination, and the possibility of avoiding using glycopeptide, in children with febrile neutropenic episodes induced by chemotherapy.A retrospective study was made, including children treated for a febrile neutropenic episode (absolute neutrophile count < 0.5 x 10(9)/l) by a piperacillin-tazobactam-netilmicin combination. If fever persisted 48 hours after the beginning of antibiotic therapy, a glycopeptide could be added. The responses to the treatment were defined as follows: 1) total success (no fever or documented infection) at 48 hours and at 72 hours following the beginning of treatment; 2) partial success (apyrexia beyond 72 hours without any therapeutic change); 3) failure (persistent infectious signs 48 hours after the introduction of glycopeptide).Sixty-nine episodes were assessable, corresponding to 41 patients, treated for a solid tumour (29), an acute leukaemia in remission (11), or a metabolic disease (1). The febrile episodes were divided into fever of unknown origin (71%), microbiologically documented fever (12%), and clinically documented fever (17%). No death occurred, no toxicity was reported. With this antibiotic therapy, total success at 72 hours was observed in 72% in case of fever of unknown origin and 45% in case of documented infections. The success rate reached 84% when a glycopeptide was added (30% of the cases).The piperacillin-tazobactam-netilmicin combination is very effective and well tolerated in probabilistic treatment of febrile neutropenia induced by chemotherapy, but does not allow to decreasing the frequency of glycopeptide administration." @default.
- W2083129612 created "2016-06-24" @default.
- W2083129612 creator A5007701213 @default.
- W2083129612 creator A5017372134 @default.
- W2083129612 creator A5021388465 @default.
- W2083129612 creator A5037694078 @default.
- W2083129612 creator A5037737991 @default.
- W2083129612 creator A5049885686 @default.
- W2083129612 date "2005-06-01" @default.
- W2083129612 modified "2023-09-28" @default.
- W2083129612 title "Traitement des épisodes de neutropénie fébrile chimio-induite de l'enfant par l'association pipéracilline–tazobactam et nétilmicine" @default.
- W2083129612 cites W117097227 @default.
- W2083129612 cites W1571178250 @default.
- W2083129612 cites W1969978663 @default.
- W2083129612 cites W1984864482 @default.
- W2083129612 cites W2011762241 @default.
- W2083129612 cites W2018771059 @default.
- W2083129612 cites W2044956217 @default.
- W2083129612 cites W2054715363 @default.
- W2083129612 cites W2061287651 @default.
- W2083129612 cites W2062860160 @default.
- W2083129612 cites W2073156110 @default.
- W2083129612 cites W2082201258 @default.
- W2083129612 cites W2095391243 @default.
- W2083129612 cites W2107901800 @default.
- W2083129612 cites W2111723930 @default.
- W2083129612 cites W2112555864 @default.
- W2083129612 cites W2143769596 @default.
- W2083129612 cites W2166507164 @default.
- W2083129612 cites W2166858780 @default.
- W2083129612 cites W2415069422 @default.
- W2083129612 cites W2416661931 @default.
- W2083129612 cites W84119309 @default.
- W2083129612 doi "https://doi.org/10.1016/j.medmal.2005.04.004" @default.
- W2083129612 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15982848" @default.
- W2083129612 hasPublicationYear "2005" @default.
- W2083129612 type Work @default.
- W2083129612 sameAs 2083129612 @default.
- W2083129612 citedByCount "2" @default.
- W2083129612 crossrefType "journal-article" @default.
- W2083129612 hasAuthorship W2083129612A5007701213 @default.
- W2083129612 hasAuthorship W2083129612A5017372134 @default.
- W2083129612 hasAuthorship W2083129612A5021388465 @default.
- W2083129612 hasAuthorship W2083129612A5037694078 @default.
- W2083129612 hasAuthorship W2083129612A5037737991 @default.
- W2083129612 hasAuthorship W2083129612A5049885686 @default.
- W2083129612 hasBestOaLocation W20831296121 @default.
- W2083129612 hasConcept C126322002 @default.
- W2083129612 hasConcept C137610392 @default.
- W2083129612 hasConcept C2775832221 @default.
- W2083129612 hasConcept C2776694085 @default.
- W2083129612 hasConcept C2777063308 @default.
- W2083129612 hasConcept C2777637488 @default.
- W2083129612 hasConcept C2777858937 @default.
- W2083129612 hasConcept C2778193466 @default.
- W2083129612 hasConcept C2778266534 @default.
- W2083129612 hasConcept C2778850193 @default.
- W2083129612 hasConcept C2778974779 @default.
- W2083129612 hasConcept C2778977604 @default.
- W2083129612 hasConcept C2778980435 @default.
- W2083129612 hasConcept C2779489039 @default.
- W2083129612 hasConcept C3019249092 @default.
- W2083129612 hasConcept C501593827 @default.
- W2083129612 hasConcept C523546767 @default.
- W2083129612 hasConcept C54355233 @default.
- W2083129612 hasConcept C71924100 @default.
- W2083129612 hasConcept C74133956 @default.
- W2083129612 hasConcept C86803240 @default.
- W2083129612 hasConcept C89423630 @default.
- W2083129612 hasConcept C90924648 @default.
- W2083129612 hasConceptScore W2083129612C126322002 @default.
- W2083129612 hasConceptScore W2083129612C137610392 @default.
- W2083129612 hasConceptScore W2083129612C2775832221 @default.
- W2083129612 hasConceptScore W2083129612C2776694085 @default.
- W2083129612 hasConceptScore W2083129612C2777063308 @default.
- W2083129612 hasConceptScore W2083129612C2777637488 @default.
- W2083129612 hasConceptScore W2083129612C2777858937 @default.
- W2083129612 hasConceptScore W2083129612C2778193466 @default.
- W2083129612 hasConceptScore W2083129612C2778266534 @default.
- W2083129612 hasConceptScore W2083129612C2778850193 @default.
- W2083129612 hasConceptScore W2083129612C2778974779 @default.
- W2083129612 hasConceptScore W2083129612C2778977604 @default.
- W2083129612 hasConceptScore W2083129612C2778980435 @default.
- W2083129612 hasConceptScore W2083129612C2779489039 @default.
- W2083129612 hasConceptScore W2083129612C3019249092 @default.
- W2083129612 hasConceptScore W2083129612C501593827 @default.
- W2083129612 hasConceptScore W2083129612C523546767 @default.
- W2083129612 hasConceptScore W2083129612C54355233 @default.
- W2083129612 hasConceptScore W2083129612C71924100 @default.
- W2083129612 hasConceptScore W2083129612C74133956 @default.
- W2083129612 hasConceptScore W2083129612C86803240 @default.
- W2083129612 hasConceptScore W2083129612C89423630 @default.
- W2083129612 hasConceptScore W2083129612C90924648 @default.
- W2083129612 hasIssue "6" @default.
- W2083129612 hasLocation W20831296121 @default.
- W2083129612 hasLocation W20831296122 @default.
- W2083129612 hasOpenAccess W2083129612 @default.
- W2083129612 hasPrimaryLocation W20831296121 @default.